Devonian reports gene expression data showing Thykamine's molecular effects in MASH model

Arctic Therapeutics enrols first patients in Phase IIa trial of AT-004 for acne vulgaris

IP Group plc portfolio company Microbiotica reports positive Phase 1b data for MB310 in ulcerative colitis

Formation Bio acquires worldwide rights to FHND5032 from CTFH

Almirall receives China approval for Seysara to treat moderate-to-severe acne

OSE Immunotherapeutics prioritises pouchitis and hidradenitis suppurativa for lusvertikimab development

WuXi Biologics collaborates with Sinorda Biomedicine for antibody development

Physiomics secures new modelling contract with Numab Therapeutics

Simcere Pharmaceutical enter licence and collaboration agreement with Boehringer Ingelheim

Insilico Medicine's ISM8969 receives US FDA IND approval for Parkinson's Disease

NeuroSense Therapeutics granted US patent protection for use of PrimeC combination in Alzheimer's disease

LEO Pharma advances delgocitinib cream into phase 3 trial for lichen sclerosus

HistoIndex partners Houston Research Institute

Formosa Pharmaceuticals licenses APP13007 ophthalmic therapy to Samil for South Korea

Eli Lilly agrees to acquire Ventyx Biosciences